Trends in peri-operative performance status following resection of high grade glioma and brain metastases: the impact on survival.
based Medicine) that gross total resection prolongs survival 12, 3 . The goal of gross total resection is not achievable in all cases of intrinsic tumours with established resection thresholds of 70-80% associated with improved survival 4, 56 . Therefore maximal safe resection is the surgical goal in intrinsic glioma to reduce the risk of acquired neurological deficit. Resection of brain metastases is well established as superior to whole brain radiotherapy alone in terms of survival 7 .
However, in any setting such resections carry the inherent risk of neurological deterioration affecting the post-operative performance status (PS) of these patients, which has the potential to impact on overall survival and may preclude adjuvant therapy 8 .
There is also the tendency to offer radical surgery only to those patients with good PS between 0 to 2.
There is currently limited data on PS changes in the post-operative period after high grade tumour surgery and its impact on overall survival 9 .
It is also not well documented if PS can improve significantly after tumour resection in those with a poor pre-operative status [10] [11] [12] .
We prospectively analysed all patients who underwent craniotomy for malignant brain tumours and metastases in our institution over a period of 8 months. The study aimed to identify the effect tumour resection on perioperative performance status and whether any neurological deterioration was temporary or permanent, if any gains in performance status were made after surgery and the impact on overall survival (OS), in order to determine the overall safety of a radical approach to tumour management.
Patients and Methods:
We prospectively collected data of all patients who underwent surgery for malignant primary brain tumour or solitary metastasis in our department between November 2013 and June 2014. A total of 94 patients were accepted for surgery after discussion in the regional neurooncology multidisciplinary The study was approved by the University Heath Board ethics review panel.
Results
Of the 75 patients, 35 were males and 40 females. The median age was 61 (range 23-78). 28 patients (50%) were aged over 65. 50 patients had primary malignant brain tumours and 25 had solitary brain metastasis. The primary sites of cancer in the metastatic group are depicted in Table 2 .
The tumour location was frontal in 45%, temporal in 23% and parietal in 16% ( Table 3 ). The median length of stay was 5 days (range 2-33 days). There was one peri-operative death in the cohort at 11 days following surgery.
3.1Peri-operative performance status
At the time of admission prior to surgery 77.3% of patients has a PS of 0 or 1 (PS 0 in 22 patients, 1
in 36 patients). 14 remained unchanged having presented as an emergency with a haemorrhagic tumour. One patient who presented PS 3 improved to PS 2 following resection of the tumour. Overall trends in PS following surgery are depicted in Figure 1 . There is no significant difference in changes in PS between the primary and metastatic tumour groups (p=0.73).
Impact on Survival
At the time of analysis, survival data was available for 68 patients. Of the 43 patients with high grade glioma, 36 (84%) of patients had died and in the 25 with metastatic tumours 18 (72%) had died. The overall median survival in the primary group was 14.83 months and 8.53 months in the metastatic group (Fig 2a) .
Among the patients with primary high grade brain tumours, the survival is better in those whose performance status remained improved or unchanged at 2 weeks post op compared to those whose performance deteriorated (Fig.2b) . Median survival in the former group is 15.67 months and 2.4 months in the latter group (p=0.005) . In the metastatic group, the median survival in those patients whose performance status remained improved or unchanged is better (8.53) than those who deteriorated (2.33) (p=0.001) Fig 2c. 
Discussion
Our prospective cohort study demonstrates that extended tumour resections of high grade intrinsic tumours and metastatic tumours is safe and beneficial. Where any neurological deterioration occurs it is transient in the majority of patients, with recovery of functional status by 2 weeks following surgery.
Furthermore, it suggests that any decisions to withhold adjuvant therapy based on performance status should be delayed at least 2 weeks from surgery. We have also demonstrated that although the risk At 10 months after surgery 56% of patients had lost functional independence. On multivariate analysis increasing age and a new motor or language deficit were associated with decreased ability to maintain functional independence. Importantly, their study demonstrated that immediate postoperative KPS score had a stronger association with overall survival than pre-operative KPS.
Several studies have highlighted the risk of acquired neurological deficit and the impact on overall and these patients were then less likely to receive chemoradiotherapy. In this series extent of resection was defined as gross total resection (GTR), near total (NTR) and subtotal resection (STR).
Overall there was a significant decrease between pre-operative and post-operative KPS measured at 6 weeks, with 39% of the cohort declining functionally. However, this was not significantly different between the GTR vs NTR and STR subgroups.
Our prospective study highlights that although changes in post-operative functional status do occur, the majority recover back to baseline PS or better following surgery. In our cohort, although 18.7% of patients had deteriorated on day one following surgery, overall 94.6% of patients were unchanged or better at 2 weeks after surgery. Importantly, the most significant gains in functional status were made at 2 weeks. This is similar to the finding of Chambless et al 9 survival with a poor functional status is of any real benefit to patients.
Limitations
This study has a number of limitations. Although all operations were carried out with the intention of maximal safe resection, post-operative imaging was not routinely undertaken and therefore confirmed extent of resection is not reported. However we intended to demonstrate the potential neurological morbidity with the intention to treat high grade gliomas and metastatic tumours radically to enable better pre-operative patient counselling and decision making in the clinical setting. We did not intend to report survival based on extent of resection but solely on PS. Our data therefore demonstrates that taking a radical approach in this setting is acceptable. Similarly we did not record post-operative adjuvant treatment regime or subsequent PS over the duration of survival, as we intended to report PS trends in the perioperative period alone. Finally, our decision to include both high grade glioma and metastatic tumours makes this a heterogeneous group, however, the risk of acquired neurological or cognitive deficit applies to both groups and we have demonstrated that there is an impact on survival in both groups.
Conclusion
With a limited overall prognosis in both high grade glioma and cerebral metastatic tumours, functional status following surgery is paramount. Our data demonstrates that while extended tumour resections of high grade intrinsic tumours and metastatic tumours is safe and beneficial, acquired changes in PS immediately after surgery are transient in the majority and the overall risk of a significant decline in PS is low. Importantly, significant gains in PS following a transient decline are seen by 2 weeks following surgery and decisions on fitness for adjuvant treatment should be delayed until at least 2 weeks in those that decline. Where there is a significant decline in PS following surgery, prognosis is very poor and patients must be counselled regarding this risk prior to surgery. Future studies of outcome and survival in high grade CNS tumours must include functional status as a factor in survival. 
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